Name: Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma (Video) | JoVE Journal
Uploaded: 2022-04-15T14:00:00.000+00:00
Duration: 7 min 53 s
Description: Learn interphase FISH on bone marrow smears for multiple myeloma diagnosis using anti-CD138 magnetic beads. This method reduces specimen demands and costs while improving clonal plasma cell detection accuracy.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

This project was supported by the Innovation Fund of WNLO 2018WNLOKF023.

This study was conducted according to the principles of the Helsinki Declaration and approved by the Ethics Committee of Zhongnan Hospital of Wuhan University (No. 2019065). The specimens were collected from a MM patient in the Department of Hematology, Zhongnan Hospital of Wuhan University (China).
1. Preparation of the BM smears
<ol>
	<li>Place the first 0.2 mL of BM solution on a clean disposable glass slide.</li>
	<li>Spread the BM smears to uniform thickness with sharp tails by quickly removing the BM. Then, dry naturally.</li>
	<li>Cover the BM films with 1 mL of Wright-Giemsa solution for approximately 10 s at room temperature.</li>
	<li>Add 1 mL of phosphate buffer to the slides. 
	NOTE: Take care to prevent the dye solution from drying or &#64258;owing off the slides.</li>
	<li>Mix the dye solution gently and maintain it for 15 min at room temperature.</li>
	<li>Rinse the slides with clean water and dry them in air at room temperature.</li>
	<li>Use forward light microscopy to detect malignant PCs. The PCs should be well dispersed.</li>
</ol>
2. FISH pre-processing of the BM smears
<ol>
	<li>Cover the hybridized area with fixative solution for 10 min to discolor and fix the PCs.
	<ol>
		<li>To prepare fresh fixative solution, mix methanol with glacial acetic acid in a volume ratio of 3:1.</li>
	</ol>
	</li>
	<li>Rinse the slide with deionized water (dH2O) and dry it in air at room temperature.</li>
	<li>Preheat a jar containing 2x SSC buffer to 56 &#176;C in a water bath. Freshly dilute the buffer to 20x SSC before use.
	<ol>
		<li>To prepare 20x SSC, thoroughly mix 176 g of sodium chloride and 88 g of sodium citrate with 800 mL of dH2O. Measure the pH and adjust to pH 5.3 &#177; 0.2. Then, add dH2O to bring the final volume to 1 L.</li>
	</ol>
	</li>
	<li>Wash the prepared BM smear in the preheated 2x SSC buffer for 10 min, followed by dipping it into deionized water at room temperature.</li>
	<li>Dehydrate the smear in an ethanol gradient (70%, 85%, and 100% ethanol, each for 1 min). Air-dry the smear for 10 min.</li>
</ol>
3. BM smear FISH and washing
NOTE: All steps were performed in a dark room to prevent fluorescence quenching.
<ol>
	<li>Add the TP53/centromere of chromosome 17 (CEP17) probe mixture to the hybridization area and cover it with a coverslip. Press gently with fine-pointed tweezers to remove air bubbles from underneath.</li>
	<li>Seal all sides of the coverslip with rubber cement to ensure good tightness.</li>
	<li>After solidification of the rubber cement, place the slide on an automatic FISH machine. Perform denaturation at 78 &#176;C for 5 min, followed by hybridization at 37 &#176;C overnight.</li>
	<li>Pick up the slide from the FISH machine. Use fine-pointed tweezers to remove the rubber cement gently.</li>
	<li>Immerse the slide in 2x SSC at room temperature for approximately 1 or 2 min to wash the coverslip off.</li>
	<li>Wash the slide in 68 &#176;C preheated 0.4x SSC/0.3% NP-40 buffer in a water bath for 2 min.
	<ol>
		<li>Prepare 0.4x SSC/0.3% NP-40 solution by thoroughly mixing 20 mL of 20x SSC (pH 5.3) with 950 mL of dH2O. Then, add 3 mL of NP-40 and mix thoroughly until completely dissolved. Measure the pH and adjust to 7.0-7.5 with NaOH. Then, add dH2O to bring the final volume of the total solution to 1 L.</li>
	</ol>
	</li>
	<li>Wash the slides with 2x SSC in a 37 &#176;C water bath for 1 min. Set upright in the dark to dry thoroughly for 10 min.</li>
	<li>Add 10 &#181;L of DAPI to the hybridized area and cover with a coverslip.</li>
</ol>
4. FISH analysis and imaging
<ol>
	<li>View the hybridized slide using a suitable filter set on a fluorescence microscope.</li>
	<li>Use a monochromatic blue fluorophore optical filter to observe the fluorescence intensity of the cell nucleus. Take cell nucleus images under a DAPI filter set.</li>
	<li>Use a chromosome centromere probe to show how many chromosomes a cell contains. Label CEP17 with green fluorescence. Use a spectrum green fluorophore optical filter to observe the location of CEP17. Take a CEP17 signals image under the green filter set.</li>
	<li>Label the TP53 gene with orange fluorescence. Use a spectrum orange fluorophore optical filter to observe TP53. Take a TP53 signals image under this set.</li>
	<li>Merge these three images and examine them for numerical abnormalities. 
	NOTE: In a normal interphase cell, two orange and two green signals are observed inside a nucleus with blue fluorescence, indicating one pair of normal chromosome 17 (Figure 1).</li>
</ol>

<ol><li>Sonneveld, P., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Treatment+of+multiple+myeloma+with+high-risk+cytogenetics%3A+a+consensus+of+the+International+Myeloma+Working+Group%5BTitle%5D)+AND+%22Blood%22%5BJournal%5D)">Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group.</a> Blood. 127, 2955-2962 (2016).</li>
<li>Radbruch, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Competence+and+competition%3A+the+challenge+of+becoming+a+long-lived+plasma+cell%5BTitle%5D)+AND+%22Nature+Reviews+Immunology%22%5BJournal%5D)">Competence and competition: the challenge of becoming a long-lived plasma cell.</a> Nature Reviews Immunology. 6, 741-750 (2006).</li>
<li>Lai, J. L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Improved+cytogenetics+in+multiple+myeloma%3A+a+study+of+151+patients+including+117+patients+at+diagnosis%5BTitle%5D)+AND+%22Blood%22%5BJournal%5D)">Improved cytogenetics in multiple myeloma: a study of 151 patients including 117 patients at diagnosis.</a> Blood. 85 (9), 2490-2497 (1995).</li>
<li>Hallek, M., Bergsagel, P. L., Anderson, K. C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Multiple+myeloma%3A+increasing+evidence+for+a+multistep+transformation+process%5BTitle%5D)+AND+%22Blood%22%5BJournal%5D)">Multiple myeloma: increasing evidence for a multistep transformation process.</a> Blood. 91, 3-21 (1998).</li>
<li>Munsh, N. C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Consensus+recommendations+for+risk+stratification+in+multiple+myeloma%3A+report+of+the+International+Myeloma+Workshop+Consensus+Panel+2%5BTitle%5D)+AND+%22Blood%22%5BJournal%5D)">Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2.</a> Blood. 117, 4696-4700 (2011).</li>
<li>Gole, L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((cIg-FISH+On+Patients+with+Multiple+Myeloma+-+A+Modified+and+Simple+Technique+Easily+Incorporated+Into+Routine+Clinical+Service%5BTitle%5D)+AND+%22Blood%22%5BJournal%5D)">cIg-FISH On Patients with Multiple Myeloma - A Modified and Simple Technique Easily Incorporated Into Routine Clinical Service.</a> Blood. 120, 4792-4792 (2012).</li>
<li>Lee, S. H., Erber, W., Porwit, A., Tomonaga, M., Peterson, L. I. C. S. I. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Hematology%2C+ICSH+guidelines+for+the+standardization+of+bone+marrow+specimens+and+reports%5BTitle%5D)+AND+%22International+Journal+of+Laboratory+Hematology%22%5BJournal%5D)">Hematology, ICSH guidelines for the standardization of bone marrow specimens and reports.</a> International Journal of Laboratory Hematology. 30, 349-364 (2008).</li>
<li>Štifter, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Combined+evaluation+of+bone+marrow+aspirate+and+biopsy+is+superior+in+the+prognosis+of+multiple+myeloma%5BTitle%5D)+AND+%22Diagnostic+Pathology%22%5BJournal%5D)">Combined evaluation of bone marrow aspirate and biopsy is superior in the prognosis of multiple myeloma.</a> Diagnostic Pathology. 5, 30(2010).</li>
<li>Huegel, A., Coyle, L., McNeil, R., Smith, A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Evaluation+of+interphase+fluorescence+in+situ+hybridization+on+direct+hematological+bone+marrow+smears%5BTitle%5D)+AND+%22Pathology%22%5BJournal%5D)">Evaluation of interphase fluorescence in situ hybridization on direct hematological bone marrow smears.</a> Pathology. 27, 86-90 (1995).</li>
<li>Jacobsson, B., Bernell, P., Arvidsson, I., Hast, R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Classical+morphology%2C+esterase+cytochemistry%2C+and+interphase+cytogenetics+of+peripheral+blood+and+bone+marrow+smears%5BTitle%5D)+AND+%22The+Journal+of+Histochemistry+and+Cytochemistry%22%5BJournal%5D)">Classical morphology, esterase cytochemistry, and interphase cytogenetics of peripheral blood and bone marrow smears.</a> The Journal of Histochemistry and Cytochemistry. 44, 1303-1309 (1996).</li>
<li>Dunning, K., Safo, A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+ultimate+Wright-Giemsa+stain%3A+60+years+in+the+making%5BTitle%5D)+AND+%22Biotechnic+%26+Histochemistry%22%5BJournal%5D)">The ultimate Wright-Giemsa stain: 60 years in the making.</a> Biotechnic & Histochemistry. 86, 69-75 (2011).</li>
<li>Woronzoff-Dashkoff, K. K. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+wright-giemsa+stain.+Secrets+revealed%5BTitle%5D)+AND+%22Clinics+in+Laboratory+Medicine%22%5BJournal%5D)">The wright-giemsa stain. Secrets revealed.</a> Clinics in Laboratory Medicine. 22, 15-23 (2002).</li>
<li>McPherson, R. A., Pincus, M. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Henry%27s+Clinical+diagnosis+and+Management+by+Laboratory+Methods+E-book%5BTitle%5D)+AND+%22Elsevier+Health+Sciences%22%5BJournal%5D)">Henry's Clinical diagnosis and Management by Laboratory Methods E-book.</a> Elsevier Health Sciences. , (2017).</li>
<li>Ross, F. M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Report+from+the+European+Myeloma+Network+on+interphase+FISH+in+multiple+myeloma+and+related+disorders%5BTitle%5D)+AND+%22Haematologica%22%5BJournal%5D)">Report from the European Myeloma Network on interphase FISH in multiple myeloma and related disorders.</a> Haematologica. 97, 1272-1277 (2012).</li>
</ol>

The authors have nothing to disclose.

The application of FISH to genetic risk stratification in MM is essential. The critical part of FISH reports is not all nucleated cells, but clonal PCs specifically purified or identified by sorting with anti-CD138 magnetic beads or marking with cytoplasmic immunoglobulin light chain &#954; or &#955;. Interphase FISH after PC sorting or cIg-FISH was found to be significant in the diagnosis of MM due to the relatively lower proportion of PCs in the BM. However, these methods have some shortcomings, including complex proce...

Multiple myeloma (MM) is a malignant plasma cell (PC) disease with strong biological heterogeneity and large individual differences in clinical efficacy, with survival periods ranging from months to decades. Cytogenetic characteristics are important prognostic indicators of MM. The risk stratification system and individualized treatments based on genetic characteristics have become topics of intense interest in clinical research on MM1. The aberrations of PCs tested in a fluorescence in situ hybridization (FISH) panel of bone marrow (BM) include del 13q14 (RB1), del 17p13 (TP53), t(4;14) (IGH/FGFR3), t(11;14) (IGH/MYEOV), t(14;16) (IGH/MAF), t(14:20) (IGH/MAFB), 1q21 (CKS1B) gain/amplification, and 1p (CDKN2C) deletion.
Standard metaphase cytogenetics should be included in the initial assessment of MM patients. Although conventional G-banded karyotyping offers the benefit of a whole-chromosome analysis, the low yield of this method leads to many false negative results2. Traditionally, PCs have been viewed as largely incapable of splitting because they are the end-stage products of B lymphocyte differentiation. This makes it difficult to obtain split images. Improved cytogenetic analysis in MM with long-term cultures (6 days) and stimulation of cultures by cytokines may be a promising method for identifying cytogenetic abnormalities in newly diagnosed MM patients3. Even when the culture time was prolonged to 6 days, however, cytogenetic abnormalities were accurately reported in 30%-50% of MM patients4. Furthermore, MM is characterized by complex cytogenetic aberrations that reflect its prognostic heterogeneity. However, the resolution of traditional chromosome banding technology is low, which may easily lead to missed detection of chromosomal abnormalities in MM.
Interphase FISH, preferably after CD138-positive magnetic bead-based PC sorting or marking with cytoplasmic immunoglobulin light chain &#954;/&#955;, is indispensable in the analysis of MM5,6. A CD138-positive selected sample is strongly recommended for the optimized yield of tumor cells. However, accurate quantitation of cytogenetic aberrations requires at least 4 mL of anticoagulated BM for PC sorting. Additionally, the combinations of either CD138 immunomagnetic bead sorting with FISH or cytoplasmic &#954;/&#955; light chain immunoglobulin with FISH testing (cIg-FISH) increase numerous experimental costs and are time-consuming.
Usually, the PC ratio is first assessed from the morphological examination of stained BM smears or BM biopsy sections7,8. BM specimens of the highest quality (first marrow aspirate samples) are used for morphological testing, whereas those sent for FISH or other detection are often the secondary aspirate samples with high ratios of dilution with peripheral blood.
As early as the 1990s, multiple studies showed that BM smears can be directly used for interstitial FISH examinations, which has proven to be a reliable and repeatable method9. An elegant study based on cell morphology and esterase cytochemistry combined with FISH of peripheral blood and BM smears confirmed its great clinical significance for elucidating chromosomal abnormalities in patients with granulocytic and lymphocytic leukemia10.
Herein, we provide a novel method for improving the success of interphase FISH detection in MM patients.

<table><tbody><tr><td>automatic FISH machine</td><td>Leica&amp;nbsp; Corporation</td><td>S500-24</td><td>FINAL Assy Thermobrite 240V</td></tr><tr><td>DAPI</td><td>Abbott Molecular Inc.</td><td>06J49-001</td><td>DAPI Counterstain</td></tr><tr><td>FISH Analysis Software</td><td>IMSTAR&amp;nbsp; Corporation</td><td>IMSTAR</td><td>FISH Analysis Software</td></tr><tr><td>FISH Probe</td><td>Abbott Molecular Inc.</td><td>05N56-020</td><td>Vysis Locus Specifc Identifer TP53 / CEP 17 FISH Probe Kit</td></tr><tr><td>Fixed volume pipette</td><td>Eppendorf China Ltd.</td><td>M33768H</td><td>10&amp;nbsp; microliter</td></tr><tr><td>Fluorescence Microscope</td><td>Olympus Corporation</td><td>BX53</td><td>Forward Fluorescence Microscope</td></tr><tr><td>Karyotype Analysis Software</td><td>IMSTAR&amp;nbsp; Corporation</td><td>IMSTAR</td><td>Karyotype Analysis Software</td></tr><tr><td>Light Microscope</td><td>Olympus&amp;nbsp; Corporation</td><td>BX41</td><td>Forward Light Microscope</td></tr><tr><td>NP-40</td><td>Abbott Molecular Inc.</td><td>07J05-001</td><td>NP-40</td></tr><tr><td>Plastic staining dyeing rack</td><td>Guangzhou Kaixiu Trading Co., Ltd.</td><td>RSJ-501</td><td>&amp;nbsp;24 slides</td></tr><tr><td>Plastic staining dyeing tank</td><td>Guangzhou Kaixiu Trading Co., Ltd.</td><td>RSJ-516</td><td>&amp;nbsp;24 slides</td></tr><tr><td>Rubber Cement</td><td>Marabu&amp;nbsp;GmbH &amp;amp; Co. KG</td><td>FixoGum&amp;nbsp;</td><td>Rubber Cement</td></tr><tr><td>SSC</td><td>Abbott Molecular Inc.</td><td>02J10-032</td><td>20&amp;times;SSC</td></tr><tr><td>Water bath</td><td>Shanghai Boxun Medical Bio-Instrument Co., Ltd.</td><td>DK-8D</td><td>Multiple Temperature Water bath</td></tr></tbody></table>

interphase fluorescence in situ hybridization of bone marrow smears of multiple myeloma

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma

Fluorescence in situ hybridization (FISH) detection is an indispensable method in genetic risk stratification in multiple myeloma (MM), which is one of the most common hematological malignancies. The identifying characteristic of MM is accumulated malignant plasma cells in bone marrow. FISH reports for MM mainly focus on purified or identified clonal plasma cells, rather than all nucleated cells, by sorting with anti-CD138 magnetic beads or marking with cytoplasmic immunoglobulin light chain &#954; or &#955;. Bone marrow interphase nuclei are usually obtained from fresh bone marrow cells. However, satisfactory enrichment of plasma cell specimens requires large amounts of fresh heparin anti-coagulated bone marrow, which cannot be obtained in the case of difficult bone marrow extraction or a bone marrow dry tap. Herein, we establish a novel method to improve the success of FISH detection on stained or unstained bone marrow smears. Bone marrow smears are easier to obtain than anticoagulated bone marrow specimens.

In the initial morphological assessment of a newly diagnosed MM patient, 15% of PCs in a BM smear were found to have larger and darker nuclei along with larger amounts of cytoplasm than normal PCs (Figure 2A). The first tube of heparin anti-coagulated BM detected by the immunophenotype technique revealed only 2.3% of the monoclonal aberrant PCs. CD138 immunomagnetic bead sorting in combination with FISH or the cIg-FISH technique is essential for obtaining an accurate FISH result. However, as...

Here, we present a protocol for improving the success of interphase fluorescence in situ hybridization detection on bone marrow smears from multiple myeloma patients.

Fluorescence in situ hybridization (FISH) detection is an indispensable method in genetic risk stratification in multiple myeloma (MM), which is one of ...

interphase-fluorescence-situ-hybridization-bone-marrow-smears

Research

JoVE Journal

Medicine

This video describes the technique of aspirating bone marrow from iliac spine and smear preparation for biopsy. In the example, we perform bone marrow aspiration from an acute myeloid leukemia (AML) patient and examine the cells to check for measurable residual disease (MRD), an important prognostic biomarker.

Bone Marrow Aspiration: A Method to Obtain Bone Marrow to Examine Cell Morphology

Complex tissue masses, from organs to tumors, are composed of various cellular elements. We elucidated the contribution of cellular phenotypes within a tissue utilizing multi-labeled fluorescent transgenic mice in combination with multiparameter immunofluorescent staining followed by spectral unmixing to decipher cell origin as well as cell characteristics based on protein expression.

Quantitative Multispectral Analysis Following Fluorescent Tissue Transplant for Visualization of Cell Origins, Types, and Interactions

A strategy to quantitatively analyze histological data in the bone marrow is presented. Confocal microscopy of fluorescently labeled cells in tissue sections results in 2-dimensional images, which are automatically analyzed. Co-localization analyses of different cell types are compared to data from simulated images, giving quantitative information about cellular interactions.

Automated Quantification of Hematopoietic Cell &#8211; Stromal Cell Interactions in Histological Images of Undecalcified Bone

We describe a high-throughput drug sensitivity assay for primary multiple myeloma cells. It consists of a reconstruction of the bone marrow microenvironment (including extracellular matrix and stroma) in multi-well plates, and a non-invasive method for longitudinal quantification of cell viability.

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Intravital fluorescence microscopy (IVFM) of the calvarium is applied in combination with genetic animal models to study the homing and engraftment of hematopoietic cells into bone marrow (BM) niches.

Combining Intravital Fluorescent Microscopy (IVFM) with Genetic Models to Study Engraftment Dynamics of Hematopoietic Cells to Bone Marrow Niches

The present protocol describes the usefulness of multiple fluorescence in situ hybridization (mFISH) and spectral karyotyping (SKY) in identifying inter-chromosomal stable aberrations in the bone marrow cells of mice after exposure to total body irradiation.

Detection of Inter-chromosomal Stable Aberrations by Multiple Fluorescence In Situ Hybridization (mFISH) and Spectral Karyotyping (SKY) in Irradiated Mice

Detection of minimal or measurable residual disease (MRD) is an important prognostic biomarker for refining risk assessment and predicting relapse in acute myeloid leukemia (AML). These comprehensive guidelines and recommendations with best practices for consistent and accurate identification and detection of MRD, may aid in making effective AML treatment decisions.

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Here we describe a protocol for multiplex fluorescent immunohistochemical staining and imaging for the simultaneous localization of multiple cancer-associated antigens in lymphoma. This protocol can be extended to the colocalization analysis of biomarkers within all tissue sections.

Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma

Here a detailed protocol to isolate and characterize bone marrow microenvironmental populations from murine models of myelodysplastic syndromes and acute myeloid leukemia is presented. This technique identifies changes in the non-hematopoietic bone marrow niche, including the endothelial and mesenchymal stromal cells, with disease progression.

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia

Here, a phosphoflow cytometry-based method is described to analyze signaling downstream of the mTORC1, JAK/STAT5, and MAPK pathways in acute human myeloid leukemia cells xenografted into mice and obtained from bone marrow aspirates. p-STAT5, p-4EBP1, p-RPS6, and p-ERK1/2 levels are simultaneously measured using a next-generation spectral flow cytometer with high sensitivity.

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Learn interphase FISH on bone marrow smears for multiple myeloma diagnosis using anti-CD138 magnetic beads. This method reduces specimen demands and costs while improving clonal plasma cell detection accuracy.

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma

Explore More Videos